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Objectives. We sought to investigate whether alterations in
cardiac high energy phosphates occur in postischemic “stunned”
human myocardium.
Background. Transient postischemic myocardial dysfunction is
a common phenomenon that occurs in a variety of clinical settings
in the absence of necrosis, and its pathogenesis is still unclear.
Cardiac high energy phosphates are reduced during ischemia, and
persistently altered myocardial high energy phosphate metabo-
lism has been suggested as a mechanism contributing to stunning.
Methods. We studied 29 patients with a first anterior myocar-
dial infarction (MI) who underwent successful reperfusion within
6 h of the onset of chest pain. These patients underwent 31P
magnetic resonance spectroscopy (MRS) a mean of 4 days after
MI for measurement of left ventricular contractility and relative
high energy phosphate metabolites. Twenty-one patients under-
went a second 31P MRS study a mean of 39 days after MI. Eight
volunteers served as control subjects.
Results. Global and infarct area wall motion scores improved
significantly between the early and late studies. No difference was
found between early cardiac phosphocreatine (PCr)/beta-
adenosine triphosphate (beta-ATP) ratios in patients and control
subjects ([mean 6 SD] 1.51 6 0.17 vs. 1.61 6 0.18, respectively,
p 5 0.17) or between early and late study results in patients
(1.51 6 0.17 vs. 1.53 6 0.17, respectively, p 5 0.6). For alpha of
0.05, the study had a 90% power to detect a 9% difference.
Conclusions. The results of this study demonstrate normal
myocardial PCr/ATP ratios in patients with myocardial stunning
after reperfusion and suggest that relative cardiac high energy
phosphates are not depleted in stunned human myocardium.
(J Am Coll Cardiol 1997;30:1228–32)
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Transient postischemic myocardial contractile dysfunction
(myocardial stunning) is a common phenomenon that may
occur in a variety of clinical settings, such as after cardiac
bypass surgery, acute myocardial infarction (MI) with early
reperfusion, exercise-induced ischemia, unstable angina and
coronary angioplasty (1). However, its pathogenesis remains
unclear and possibly multifactorial. Disturbances in high en-
ergy phosphate metabolism occur during ischemia and have
been proposed as a mechanism contributing to the contractile
dysfunction that characterizes postischemic stunned myocar-
dium (2). However, the role of altered high energy phosphates
in the development of myocardial stunning remains controver-
sial (2,3), and there are no studies of high energy phosphates in
the genesis of this phenomenon in humans. Normal high
energy phosphate metabolism is required for physiologic myo-
cardial contractile function, and phosphocreatine (PCr) and
adenosine triphosphate (ATP) are the chief myocardial high
energy phosphate compounds. Their presence and relative
concentrations can be determined in the human heart only
under physiologic conditions with spatially localized 31P mag-
netic resonance spectroscopy (MRS). The MRS approach has
detected impaired myocardial high energy phosphate metabo-
lism as a significant reduction in the myocardial PCr/beta-ATP
ratio during exercise stress in patients with coronary artery
disease (4,5) and at rest in some patients with heart failure
(6,7). We therefore used spatially localized 31P MRS to test the
hypothesis that relative myocardial high energy phosphates, as
measured by the cardiac PCr/beta-ATP ratio, are altered at
rest and could contribute to myocardial stunning in patients
undergoing early reperfusion during acute MI.
Methods
Patients. We studied 29 patients with a first anterior MI
who underwent successful reperfusion within 6 h of the onset
of chest pain. All patients had $1-mm ST segment elevation
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on at least three anterior wall leads on the admission electro-
cardiogram and developed Q waves on the follow-up ECG.
Creatine kinase-MB fraction levels peaked at 103 6 56 U/liter
(mean 6 SD) (normal value ,10 U/liter) an average of 12 6
4 h after the onset of symptoms. Twenty-seven patients re-
ceived intravenous thrombolytic agents, whereas the other 2
underwent primary percutaneous transluminal coronary angio-
plasty.
All 29 patients underwent MRS studies before hospital
discharge an average of 4 6 2 days after MI. Cardiac cathe-
terization was performed in all patients to confirm coronary
patency. The first MRS study and coronary angiography were
performed ,2 days apart. No patient had clinical or laboratory
signs of coronary reocclusion between the studies. Twenty-one
patients had a repeat MRS study during follow-up (mean 39 6
37 days after MI). Three patients died during admission, and
five refused to participate in the follow-up study. Eight normal
volunteers ,40 years old, with no history or findings of heart
disease, served as control subjects for the MRI spectroscopic
studies. Table 1 shows the clinical characteristics of the final 21
study patients.
Cardiac catheterization. Cardiac catheterization was per-
formed through the right brachial artery, using standard tech-
niques. Coronary angiography and left ventriculography were
performed in all patients. Arterial patency, defined as Throm-
bolysis in Myocardial Infarction (TIMI) grade 3 flow or better
(8) in the infarct-related artery was assessed in blinded manner
by two independent observers.
MRS studies. MRS studies of the heart were performed
with a Gyroscan ACS imaging and spectroscopy system (Phil-
ips Medical Systems), with an effective magnetic field of 1.5
tesla. Subjects were placed in the bore of the magnet in the
supine position. A surface radiofrequency coil tuned to the 31P
resonance frequency (63.83 MHz) was placed over the precor-
dium. Spectra were obtained from the apical and anterior walls
of the left ventricle, using the image-selected in vivo spectros-
copy (ISIS) technique (9) as a localization technique for
selecting a volume of interest from which the signal was
obtained (nominal volume ;24 cm3). Signal acquisition was
gated by the ECG with a repetition time of 2,500 ms. Trigger
delay was 200 ms; 512 measurements were obtained over
;21.5 min. After processing, the area under each peak was
determined by manual fitting with computer assistance. Skel-
etal muscle was consistently avoided when positioning the
spectroscopic region of interest with MRI guidance. We cor-
rected for blood contamination of the spectra using the
2,3-diphosphoglycerate (2,3-DPG) doublet resonances from
blood as reference. A blood ATP signal corresponding to 15%
of the integrated signal from the two 2,3-DPG peaks was
subtracted from the beta-ATP value before calculation of
metabolite ratios (10), which were corrected for partial satu-
ration effects (11). An exponential multiplication function with
a line-broadening factor of 12 Hz was applied to the signal
before Fourier transformation to improve the signal to noise
ratio (mean of 13 for PCr and 9.5 for ATP). For baseline
correction, we applied polynomial subtraction. The PCr/beta-
ATP ratio was calculated for each patient. Inorganic phos-
phate could not be measured because of its low concentration
and overlap with the 2,3-DPG peak from the blood. Repro-
ducibility of MRS measures of the cardiac PCr/ATP ratio was
evaluated in separate studies 1 week apart in a small number of
normal volunteers, and consistent findings were observed
(1.68 6 0.04 vs. 1.69 6 0.02).
Magnetic resonance (MR) images of the heart were ob-
tained with the same equipment and the 1H body coil. Cine
MR imaging of the left ventricle was performed using a
gradient-echo imaging sequence with a flip angle of 35°, an
echo time of 6 ms and a repetition time equal to the RR
interval. The acquisition matrix was 128 3 128, and the slice
thickness was 10 mm oriented along the long axis of the left
ventricle. From these images, we derived an imaging plane for
subsequent left ventricular (LV) short-axis cine MR images.
For the purpose of evaluating regional contractility, the left
Table 1. Patient Characteristics
Pt
No.
Age (yr)/
Gender
Dt MRS
(days)
1st PMI MRS
(days)
1 59/M 36 6
2 56/M 35 2
3 58/F 21 2
4 52/M 133 3
5 68/M 14 1
6 53/M 131 4
7 53/M 21 4
8 70/M 75 5
9 36/M 51 3
10 60/F 45 1
11 37/F 22 3
12 78/F 29 5
13 79/F 14 6
14 74/M 19 6
15 72/M 17 3
16 42/M 8 4
17 35/M 12 4
18 63/F 30 6
19 49/M 84 5
20 65/M 16 5
21 53/M 8 6
F 5 female; M 5 male; MRS 5 magnetic resonance spectroscopy; PMI 5
postmyocardial infarction; Pt 5 patient; Dt 5 difference in time between early
and follow-up studies.
Abbreviations and Acronyms
ATP 5 adenosine triphosphate
2,3-DPG 5 2,3-diphosphoglycerate
ECG 5 electrocardiogram
LV 5 left ventricular
MI 5 myocardial infarction
MR 5 magnetic resonance
MRS 5 magnetic resonance spectroscopy
PCr 5 phosphocreatine
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ventricle was divided into 16 segments, as proposed by the
American Society of Echocardiography (12). Regional wall
motion was assessed in blinded manner by two observers using
a six-point scoring system as follows: 0 5 hyperkinesia; 1 5
normal function; 2 5 mild hypokinesia; 3 5 hypokinesia; 4 5
akinesia; 5 5 dyskinesia (13). A global left ventricle function
score was calculated as the average of regional scores. The
observers had no knowledge of the time of the study (early or
late) or the clinical characteristics of the patients. Each seg-
ment assessed for contractility represented at least 12 to
18 cm3 of tissue. Because 18 of 21 patients had three regions of
dysfunction, and MRS studies were performed at the same
examination without repositioning of the subject, the LV
region interrogated metabolically with spectroscopy (nominal
size 24 cm3) was well contained in the region of dysfunction (24
to 54 cm3).
Statistical analysis. Results are expressed as mean value 6
SD. Comparisons between values obtained during the early
and late studies were performed with the Wilcoxon test.
Calculations were computed using the Statistical Analysis
System (SAS Institute). During the design of the study, we
calculated that a sample size of 16 patients would be necessary
to demonstrate a 10% difference in PCr/ATP ratios between
baseline and follow-up studies with a power of 90%. Therefore,
a study group of 21 patients should have sufficient power to
detect a 9% difference at the 0.05 level of confidence.
Results
Regional wall motion. Mean global LV function score was
1.60 6 0.35 during the in-hospital studies and improved
spontaneously during follow-up to 1.20 6 0.30 (p , 0.0001).
Some regional wall motion scores (Fig. 1) also showed spon-
taneous improvement, decreasing from 2.46 6 0.68 to 1.54 6
0.78, from 2.0 6 0.89 to 1.40 6 0.75 and from 2.37 6 0.71 to
1.41 6 0.59 in the septal, anteroseptal and anterior regions,
respectively (p , 0.001 for all differences). Other LV wall
segments did not show significant changes in score between the
in-hospital and follow-up studies.
31P MRS. Figure 2 shows a representative example of a 31P
MR spectrum acquired 4 days after anterior MI. The mean
myocardial PCr/beta-ATP ratio was similar between the early
and late studies in all patients (1.51 6 0.17 and 1.53 6 0.17,
p 5 0.6) (Fig. 3). These values where similar to the mean
PCr/beta-ATP ratio observed in normal volunteers (1.61 6
0.18, p 5 0.17) and to those reported by others (4,14). Because
LV function scores did not return to normal levels in all
patients, we also evaluated myocardial PCr/beta-ATP ratios in
subsets of patients with complete (n 5 8) and partial improve-
ment (n 5 13) of LV function. Early and late ratios were
Figure 3. Myocardial PCr/ATP ratios in the early and late studies.
Figure 1. Mean regional wall motion scores in the septal, anteroseptal
and anterior LV regions.
Figure 2. Representative example of spatially localized cardiac 31P
MR spectrum from a patient 4 days after ischemic episode.
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1.51 6 0.16 versus 1.56 6 0.18 (p 5 0.21) and 1.51 6 0.18
versus 1.52 6 0.19 (p 5 0.7), respectively, in patients with
complete and partial improvement in LV function scores.
There was no difference between early and late ratios in both
groups (p 5 0.54). In addition, no correlation was found
between early and late regional wall motion scores and PCr/
beta-ATP ratios (p 5 0.61 and 0.50, respectively). Thus,
anterior myocardial PCr/beta-ATP ratios were normal in these
patients with transient ventricular dysfunction after severe
ischemic insult.
Discussion
Transient postischemic dysfunction was first described in
1975 by Heyndrickx et al. (15) in a canine model, and
numerous clinical and experimental studies have since investi-
gated this phenomenon. In 1982, Braunwald and Kloner (2)
coined the term “stunned myocardium” for the reversibly
injured, nonnecrotic myocardial tissue whose functional recov-
ery is delayed after reperfusion (2,16).
Many mechanisms have been proposed to explain the
pathogenesis of myocardial stunning. Insufficient production of
energy by the mitochondria, abnormalities in the use of energy
by the myofibrils, impaired response to sympathetic stimula-
tion, extracellular matrix damage, calcium overload, excitation-
–contraction uncoupling and free radical production have all
been suggested, but none have been conclusively proved
(17–19), and most are difficult or impossible to investigate in
humans under physiologic conditions.
Metabolic changes related to myocardial stunning. Severe
abnormalities in metabolism and metabolite depletion are
consistently observed after prolonged, irreversible ischemic
injury, whereas metabolic abnormalities in reversibly stunned
myocardium are more subtle (20,21). Canine models of myo-
cardial stunning are characterized not only by modest nucleo-
tide depletion that may persist for days but also by PCr levels
that normalize early after reperfusion (22,23). This rapid
resynthesis of PCr and essentially normal PCr/ATP levels have
been taken as evidence that a defect in mitochondrial synthesis
of ATP is not present in experimentally stunned myocardium
(22,23).
Our objective in the present study was to evaluate whether
alterations in myocardial PCr/ATP ratios were present and
could contribute to postischemic dysfunction in humans. We
observed contractile impairment that spontaneously improved
during follow-up in patients who underwent rapid reperfusion
for acute anterior MI. Myocardial high energy phosphates
were measured using spatially localized 31P MRS, and no
significant differences in cardiac PCr/beta-ATP ratios were
found between our patients early after ischemia and normal
volunteers. Similarly, this ratio did not change significantly in
our patients during follow-up, despite a significant improve-
ment in regional wall motion.
These findings are consistent with many previous observa-
tions of normal PCr/ATP recovery in experimentally stunned,
noninfarcted myocardium. Several studies (24–26) in isolated
hearts have demonstrated a rapid return of high energy
phosphates to their baseline levels shortly after reperfusion,
long before full contractile recovery. Similar observations of
normal or high PCr/ATP ratios have been made in intact
animals after coronary occlusion (27). Likewise, several inves-
tigations (28,29) show a dissociation between myocardial ATP
levels and contractile function in stunned myocardium and an
improvement in contractility of stunned myocardium during
inotropic stimulation. Others (20) showed that the PCr/ATP
ratio achieved supranormal levels 3 h after experimental
reperfusion. An overshoot of the PCr/beta-ATP ratio was not
observed here most likely because of the delay of several days
between reperfusion and MRS evaluation. Thus, to our knowl-
edge, these are the first observations of high energy phosphates
in stunned human myocardium, with normal cardiac PCr/beta-
ATP ratios consistent with those of previous experimental
studies in postischemic, transiently dysfunctional noninfarcted
myocardium.
Limitations of the study. A potential limitation of this
study is that the region of interest included both subendocar-
dial and subepicardial tissue; thus, differences in high energy
phosphate ratios between regions of the myocardium could not
be resolved. We cannot exclude the possibility that some
degree of partial volume averaging from skeletal muscle,
chamber blood and unstunned myocardium may have oc-
curred, but we believe this to be relatively small and, if present,
most likely similar between early and late studies. Another
potential limitation is the use of PCr/beta-ATP ratios to index
high energy phosphate metabolism rather than measures of
absolute PCr or ATP concentrations or rates of high energy
phosphate synthesis. PCr synthesis rates through the creatine
kinase reaction have been measured in the human heart with
31P MRS (30), but such measures have not been made in
patients with cardiac disease because the measures require
high field (4 T) systems generally not available in hospital
settings. Recently, Yabe et al. (31) used 31P MRS to measure
the ATP and PCr content of human myocardium with revers-
ible ischemia or scar diagnosed by exercise thallium scintigra-
phy, and a reduction in PCr was observed. However, measures
of metabolite contents are not routinely performed and have
not been rigorously validated with other techniques in the
current setting. Therefore, the current data demonstrating
normal cardiac PCr/beta-ATP ratios in stunned human myo-
cardium cannot exclude the possibility of a parallel reduction
in both PCr and ATP concentrations. However, such a similar
reduction in both PCr and ATP after ischemia seems unlikely
because PCr declines more dramatically than ATP during brief
human cardiac ischemia (4,5), and PCr in animals recovers
fully in viable tissues but not in nonviable myocardium (21,22).
In our patients, high energy phosphate ratios would probably
have reached new steady state levels by 4 days after MI, when
the initial study was conducted. It is clear that the cardiac
PCr/ATP ratio can be used to detect abnormalities in high
energy phosphate metabolism in humans because this ratio is
acutely reduced during exercise stress in patients with ischemic
heart disease (4,5) and chronically reduced in subjects with
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severe heart failure (7,8). We therefore suggest that the
normal and unchanged cardiac PCr/beta-ATP ratios at rest in
postischemic stunned human myocardium in the current study
indicate that high energy phosphate depletion is not present
and does not contribute to human myocardial stunning in this
setting.
Conclusions. The primary pathophysiologic consequence
of myocardial ischemia is altered metabolism, which contrib-
utes to impaired contractile function. Although a persistent
abnormality in metabolism after ischemia could contribute to
dysfunction during reperfusion, the observations of the present
study demonstrate that myocardial PCr/beta-ATP ratios are
not reduced in postischemic transiently dysfunctional human
myocardium. These findings suggest that relative myocardial
high energy phosphate depletion is not present in patients with
myocardial stunning after reperfusion.
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